{"id":941048,"date":"2026-03-02T11:06:38","date_gmt":"2026-03-02T16:06:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/"},"modified":"2026-03-02T11:06:38","modified_gmt":"2026-03-02T16:06:38","slug":"galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/","title":{"rendered":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, March  02, 2026  (GLOBE NEWSWIRE) &#8212; Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that company management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 at 10:40 a.m. ET.<\/p>\n<p align=\"justify\">A live webcast of the Company\u2019s presentation will be available under the \u201cNews &amp; Events\u201d tab in the Investor Calendar section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1X4JveQ-hT7GvASYy3THg3P5hkYPJPjVwuupCAcVooGfskzQXvj_ekbbLeDVT-CbapoLrcSTJvn5q82br6Adh3LM-HNS70lT_FeEFxaGuKwqRmKptF8MZLxUYfBTJTpLdRwtC2jnqX26yDgXftPxkq_O24m-BOYA18_jMF-CQsA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.galecto.com\/news-and-events\/events<\/a>. An archived replay will be accessible for 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Galecto, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Galecto, Inc.\u00a0is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics to transform treatment of a broad spectrum of hematological cancers. Galecto\u2019s pipeline includes a highly differentiated mutant calreticulin (mut-CALR)-driven myeloproliferative neoplasm portfolio targeting essential thrombocythemia and myelofibrosis. Galecto\u2019s pipeline also includes GB3226, a first-in-class preclinical dual inhibitor of ENL-YEATS and FLT3 for the treatment of multiple genetic subsets of acute myeloid leukemia.<\/p>\n<p>Media Contact:<br \/>Lia Dangelico<br \/>Deerfield Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zU4XP3nd7FL6chd-bzZlO0Mhx5dkfGoxbNcVziTmGD-mOUPKdJGQGj7vyCQDROpol8mnHq8_IRi9QEGQPffDjrJlApmAZ0NG7Dwg7sXLeYV0s_OfMHahZLXOmQGGYFNh1mnulpISAEHMl3ZQdnWzQg==\" rel=\"nofollow\" target=\"_blank\">lia.dangelico@deerfieldgroup.com<\/a><\/p>\n<p>Investor Contact:<br \/>Brian Ritchie<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UTlfuP0eIU94h_IOe2PtizqXWGQfaD3Cgh9Q3qQUi0lGtMjvY_ype4u2pM3M2sDwO8oAp7UYBftMMObk3WqOUprIDnAVowap_2_NPXleIbGBEmHcsMUJ5nSbXUJpN3jB\" rel=\"nofollow\" target=\"_blank\">britchie@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjkyZTZhNGYtZDJmNy00OGZkLWE0NzMtNzM1NjZjODQyNDVmLTUwMDA2OTk5Ny0yMDI2LTAzLTAyLWVu\/tiny\/Galecto-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, March 02, 2026 (GLOBE NEWSWIRE) &#8212; Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that company management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 at 10:40 a.m. ET. A live webcast of the Company\u2019s presentation will be available under the \u201cNews &amp; Events\u201d tab in the Investor Calendar section of the Company\u2019s website at https:\/\/ir.galecto.com\/news-and-events\/events. An archived replay will be accessible for 30 days following the event. About Galecto, Inc. Galecto, Inc.\u00a0is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics to transform treatment of a broad spectrum of hematological cancers. Galecto\u2019s pipeline includes a highly &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-941048","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, March 02, 2026 (GLOBE NEWSWIRE) &#8212; Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that company management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 at 10:40 a.m. ET. A live webcast of the Company\u2019s presentation will be available under the \u201cNews &amp; Events\u201d tab in the Investor Calendar section of the Company\u2019s website at https:\/\/ir.galecto.com\/news-and-events\/events. An archived replay will be accessible for 30 days following the event. About Galecto, Inc. Galecto, Inc.\u00a0is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics to transform treatment of a broad spectrum of hematological cancers. Galecto\u2019s pipeline includes a highly &hellip; Continue reading &quot;Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-02T16:06:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference\",\"datePublished\":\"2026-03-02T16:06:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/\"},\"wordCount\":188,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/\",\"name\":\"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\",\"datePublished\":\"2026-03-02T16:06:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk","og_description":"BOSTON, March 02, 2026 (GLOBE NEWSWIRE) &#8212; Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that company management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 at 10:40 a.m. ET. A live webcast of the Company\u2019s presentation will be available under the \u201cNews &amp; Events\u201d tab in the Investor Calendar section of the Company\u2019s website at https:\/\/ir.galecto.com\/news-and-events\/events. An archived replay will be accessible for 30 days following the event. About Galecto, Inc. Galecto, Inc.\u00a0is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics to transform treatment of a broad spectrum of hematological cancers. Galecto\u2019s pipeline includes a highly &hellip; Continue reading \"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-02T16:06:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference","datePublished":"2026-03-02T16:06:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/"},"wordCount":188,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/","name":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==","datePublished":"2026-03-02T16:06:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2Mjk2NiM3NDU5NTYxIzUwMDA2OTk5Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galecto-to-participate-in-leerink-partners-2026-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=941048"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/941048\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=941048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=941048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=941048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}